Responses
Immunotherapy biomarkers
Original research
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study
Compose a Response to This Article
Other responses
No responses have been published for this article.
